Pirfenidone in Adult Hospitalized Patients With COVID-19
NCT05713292
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
168
Enrollment
OTHER
Sponsor class
Conditions
COVID-19 Pneumonia
Interventions
DRUG:
Pirfenidone Oral Product
DRUG:
Pirfenidone placebo
Sponsor
Capital Medical University